Jamp-Rehydralyte: Out of specification
Last updated
Summary
Product
Jamp-Rehydralyte
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Jamp-Rehydralyte 5.1 g |
Jamp-Rehydralyte |
NPN 80027403 |
Powder for Solution |
2-Hydroxy-1,2,3-propanetricarboxylic acid sodium salt (1:3) 530.0 mg, 2-Hydroxy-1,2,3-propanetricarboxylic acid tripotassium salt 390.0 mg, D-glucose 3560.0 mg, Sodium Chloride 470.0 mg |
2039 |
Issue
Loss on drying is out of specification in the affected batch.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Jamp Pharma Corporation.
1310 Nobel,
Boucherville, Québec,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74428
Get notified
Receive notifications for new and updated recalls and alerts by category.